Arcus Biosciences, Inc. SEC filings RCUS
Arcus Biosciences, Inc. has 609 filings in SEC EDGAR's recent list, going back to Dec 15, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 22, 2026 | — |
| 424B5 | Prospectus supplement | Oct 21, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 25, 2026 | — |
| S-8 | Employee stock plan registration | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Oct 31, 2025 | — |
| 424B5 | Prospectus supplement | Oct 30, 2025 | — |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| 424B5 | Prospectus supplement | Feb 18, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 21, 2024 | — |
| S-8 | Employee stock plan registration | Feb 21, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 28, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| S-3ASR | Automatic shelf registration | Oct 11, 2022 | — |
| S-8 | Employee stock plan registration | Feb 23, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| 424B5 | Prospectus supplement | May 29, 2020 | — |
| 424B5 | Prospectus supplement | May 28, 2020 | — |
| S-3ASR | Automatic shelf registration | May 27, 2020 | — |
| S-8 | Employee stock plan registration | Mar 5, 2020 | — |
| 424B5 | Prospectus supplement | Apr 26, 2019 | — |
| S-3 | Shelf registration | Apr 2, 2019 | — |
| S-8 | Employee stock plan registration | Mar 5, 2019 | — |
| S-8 | Employee stock plan registration | Mar 16, 2018 | — |
| 424B4 | Prospectus | Mar 16, 2018 | — |
| S-1MEF | Filing | Mar 14, 2018 | — |
| S-1/A | Amended registration statement | Mar 9, 2018 | — |
| S-1/A | Amended registration statement | Mar 5, 2018 | — |
| S-1 | Registration statement | Feb 16, 2018 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RCUS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hayward, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1724521
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.